Market research
S66.AU Star Combo Pharma Limited
AU AUD Consumer Defensive
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 2.1%
- Beta
- 0.35
Community
Investor discussion
1 comment
Sign in to join the S66.AU discussion.
5 years, 6 months ago
Star Combo Pharma Limited is currently in a long term downtrend where the price is trading 15.7% below its 200 day moving average.
From a valuation standpoint, the stock is 85.3% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.0.
Star Combo Pharma Limited's total revenue sank by 30.3% to $15M since the same quarter in the previous year.
Its net income has increased by 143.0% to $530K since the same quarter in the previous year.
Finally, its free cash flow grew by 0.0% to $-2M since the same quarter in the previous year.
Based on the above factors, Star Combo Pharma Limited gets an overall score of 3/5.